1-23874679-G-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001841.3(CNR2):c.939C>T(p.Cys313Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00112 in 1,614,172 control chromosomes in the GnomAD database, including 40 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00061 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0012 ( 37 hom. )
Consequence
CNR2
NM_001841.3 synonymous
NM_001841.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.35
Publications
2 publications found
Genes affected
CNR2 (HGNC:2160): (cannabinoid receptor 2) The cannabinoid delta-9-tetrahydrocannabinol is the principal psychoactive ingredient of marijuana. The proteins encoded by this gene and the cannabinoid receptor 1 (brain) (CNR1) gene have the characteristics of a guanine nucleotide-binding protein (G-protein)-coupled receptor for cannabinoids. They inhibit adenylate cyclase activity in a dose-dependent, stereoselective, and pertussis toxin-sensitive manner. These proteins have been found to be involved in the cannabinoid-induced CNS effects (including alterations in mood and cognition) experienced by users of marijuana. The cannabinoid receptors are members of family 1 of the G-protein-coupled receptors. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 1-23874679-G-A is Benign according to our data. Variant chr1-23874679-G-A is described in ClinVar as [Benign]. Clinvar id is 756679.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.35 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000611 (93/152282) while in subpopulation SAS AF = 0.0182 (88/4822). AF 95% confidence interval is 0.0152. There are 3 homozygotes in GnomAd4. There are 74 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CNR2 | NM_001841.3 | c.939C>T | p.Cys313Cys | synonymous_variant | Exon 2 of 2 | ENST00000374472.5 | NP_001832.1 | |
CNR2 | XM_011540629.4 | c.939C>T | p.Cys313Cys | synonymous_variant | Exon 2 of 2 | XP_011538931.1 | ||
CNR2 | XM_017000261.3 | c.939C>T | p.Cys313Cys | synonymous_variant | Exon 3 of 3 | XP_016855750.1 | ||
CNR2 | XM_047444833.1 | c.939C>T | p.Cys313Cys | synonymous_variant | Exon 2 of 2 | XP_047300789.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000611 AC: 93AN: 152164Hom.: 3 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
93
AN:
152164
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00234 AC: 588AN: 251476 AF XY: 0.00319 show subpopulations
GnomAD2 exomes
AF:
AC:
588
AN:
251476
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00118 AC: 1718AN: 1461890Hom.: 37 Cov.: 60 AF XY: 0.00171 AC XY: 1247AN XY: 727248 show subpopulations
GnomAD4 exome
AF:
AC:
1718
AN:
1461890
Hom.:
Cov.:
60
AF XY:
AC XY:
1247
AN XY:
727248
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33480
American (AMR)
AF:
AC:
2
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
26136
East Asian (EAS)
AF:
AC:
2
AN:
39700
South Asian (SAS)
AF:
AC:
1571
AN:
86258
European-Finnish (FIN)
AF:
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
51
AN:
1112010
Other (OTH)
AF:
AC:
86
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
103
206
308
411
514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000611 AC: 93AN: 152282Hom.: 3 Cov.: 32 AF XY: 0.000994 AC XY: 74AN XY: 74448 show subpopulations
GnomAD4 genome
AF:
AC:
93
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
74
AN XY:
74448
show subpopulations
African (AFR)
AF:
AC:
3
AN:
41568
American (AMR)
AF:
AC:
0
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
88
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2
AN:
68024
Other (OTH)
AF:
AC:
0
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.520
Heterozygous variant carriers
0
4
8
13
17
21
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
33
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jul 04, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.